ESTRO 2024 - Abstract Book

S2750

Interdisciplinary - Global health

ESTRO 2024

4. Srivastava A, Vischioni B, Fiore MR, Vitolo V, Fossati P, Iannalfi A, Tuan JK, Orecchia R. Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy. J Radiat Res. 2013 Jul;54 Suppl 1(Suppl1):i43-8. doi: 10.1093/jrr/rrt057. PMID: 23824125; PMCID: PMC3700519. 5. Krcek R, Leiser D, García-Marqueta M, Bolsi A, Weber DC. Long Term Outcome and Quality of Life of Intracranial Meningioma Patients Treated with Pencil Beam Scanning Proton Therapy. Cancers (Basel). 2023 Jun 7;15(12):3099. doi: 10.3390/cancers15123099. PMID: 37370709; PMCID: PMC10296362. 6. Cao, J.; Zhang, X.; Jiang, B.; Chen, J.; Wang, X.; Wang, L.; Sahoo, N.; Zhu, X.R.; Ye, R.; Blanchard, P.; et al. Intensity modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiother. Oncol. 2021, 160, 32–39 7. Sharma, S.; Zhou, O.; Thompson, R.; Gabriel, P.; Chalian, A.; Rassekh, C.; Weinstein, G.S.; O’Malley, B.W.; Aggarwal, C.; Bauml, J.; et al. Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer. Int. J. Part Ther. 2018, 5, 11–17. 8. Grant, S.R.; Hutcheson, K.A.; Ye, R.; Garden, A.S.; Morrison, W.H.; Rosenthal, D.I.; Gunn, G.B.; Fuller, C.D.; Phan, J.; Reddy, J.P.; et al. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother. Oncol. 2020, 148, 133–139. 9. Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Brédart A, Söderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000 Sep;36(14):1796-807. doi: 10.1016/s0959-8049(00)00186-6. PMID: 10974628. 10. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A, Hofmeister D, Krejovic Trivic S, Loo S, Chie WC, Bjordal K, Brokstad Herlofson B, Grégoire V, Licitra L; EORTC Quality of Life and the EORTC Head and Neck Cancer Groups. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head Neck. 2019 Jun;41(6):1725-1737. doi: 10.1002/hed.25609. Epub 2019 Jan 12. PMID: 30636188. 11. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A; EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer. 2010 Apr;46(6):1033-40. doi: 10.1016/j.ejca.2010.01.012. Epub 2010 Feb 22. PMID: 20181476. 12. Murphy M, Lami A, Moret-Tatay C. An Italian Adaptation of the Brief Resilient Coping Scale (BRCS) and Attitudes During the Covid-19 Outbreak. Front Psychol. 2021 Jul 1;12:641213. doi: 10.3389/fpsyg.2021.641213. PMID: 34276468; PMCID: PMC8281311.

13. Sinclair VG, Wallston KA. The development and psychometric evaluation of the Brief Resilient Coping Scale. Assessment. 2004 Mar;11(1):94-101. doi: 10.1177/1073191103258144. PMID: 14994958.

2444

Digital Poster